BioNTech SE has announced the appointment of Guido Oelkers, Ph.D., as its new Chief Executive Officer, effective by February 1, 2027. Oelkers will succeed Prof. Ugur Sahin, M.D., and brings over 30 years of experience in the biotechnology and pharmaceutical industries.
Who to call at BioNTech, and when
A new leader at BioNTech brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day BioNTech raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at BioNTech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioNTech. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
BioNTech
Location
Mainz, Rhineland Palatinate, Germany
About
BioNTech is a biopharmaceutical company dedicated to harnessing the power of the immune system to develop innovative cancer therapies and treatments for other serious diseases.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioNTech changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MainzBiotechnologyHealth CareTherapeuticsBiopharma